Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.

scientific article published in April 2004

Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.0904-2512.2004.00118.X
P8608Fatcat IDrelease_w3qgbl77kbbqtea7lgeg65obo4
P698PubMed publication ID15061708

P50authorChun-Pin ChiangQ40506951
Andy SunQ44036590
Julia Yu-Fong ChangQ59160267
Jeng-Tzung WangQ114520059
P2093author name stringYi-Ping Wang
Yu-Shan Chen
Bu-Yuan Liu
P433issue4
P921main subjectoral squamous cell carcinomaQ18553522
P304page(s)209-217
P577publication date2004-04-01
P1433published inJournal of Oral Pathology & MedicineQ15724686
P1476titleExpression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan
P478volume33

Reverse relations

cites work (P2860)
Q37022410Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma
Q49414583Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review
Q36713414Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasis
Q35067200Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances
Q92531037Hepatocyte Growth Factor Receptor overexpression predicts reduced survival but its targeting is not effective in unselected HNSCC patients
Q33607965Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment
Q41052677Identification of a combined biomarker for malignant transformation in oral submucous fibrosis
Q37490555MET genetic abnormalities unreliable for patient selection for therapeutic intervention in oropharyngeal squamous cell carcinoma
Q38118439Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition
Q36375213Prognostic value of c-Met expression in oral squamous cell carcinoma
Q36446461Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma
Q91306867Role of c-Met expression on prognosis of head and neck cancer: A literature review and meta-analysis
Q38167258Role of met axis in head and neck cancer
Q30494514The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma
Q34639763The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Q39264794Trending Speculations of Tumor-Initiating Cells in Squamous Cell Cancers of Head and Neck

Search more.